Clearmind Medicine Inc. Share Premium
Clearmind Medicine Inc. (CMND) had Share Premium of $35.95 million as of 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes
ifrs-full:SharePremium · last filed 2026-03-12
- 2023-01-31: Share Premium 17.69M CAD.
- 2022-10-31: Share Premium 9.15M CAD.
- 2021-10-31: Share Premium 7.91M CAD.
CAD
| Period end | Share Premium |
|---|---|
| 2023-01-31 | 17.69M CAD 6-K · filed 2023-03-17 |
| 2022-10-31 | 9.15M CAD 6-K · filed 2023-03-17 |
| 2021-10-31 | 7.91M CAD 20-F · filed 2023-02-06 |
USD
| Period end | Share Premium |
|---|---|
| 2026-01-31 | $35.95M 6-K · filed 2026-03-12 |
| 2025-10-31 | $26.40M 6-K · filed 2026-03-12 |
| 2025-07-31 | $25.57M 6-K · filed 2025-09-11 |
| 2025-04-30 | $25.34M 6-K · filed 2025-06-12 |
| 2025-01-31 | $24.76M 6-K · filed 2025-03-13 |
| 2024-10-31 | $24.17M 20-F · filed 2026-01-20 |
| 2024-07-31 | $23.80M 6-K · filed 2024-09-16 |
| 2024-04-30 | $22.76M 6-K · filed 2024-06-13 |
| 2024-01-31 | $22.52M 6-K · filed 2024-03-19 |
| 2023-10-31 | $17.13M 20-F · filed 2025-01-22 |
| 2023-04-30 | $14.76M 6-K · filed 2023-06-14 |
| 2022-10-31 | $6.71M 20-F/A · filed 2024-03-18 |